$ACB $TLRY $CGC: Aurora Cannabis Posts Big Revenue Surge but Swings to a Loss

Date: Tuesday, February 12th, 2019

Stock(s) mentioned: , ,

Source: TheStreet (https://www.thestreet.com)

Summary: The Canadian cannabis company sees sales surge in its fiscal second quarter.

Full article address: https://www.thestreet.com/markets/aurora-cannabis-posts-second-quarter-loss-revenue-surges-14862290

Related News:

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$ACB: Aurora Makes Its Case to Be Pot’s Dominant Player

$APHA $ACB: Better Buy: Aphria vs. Aurora Cannabis

$ACB: You’ll Never Guess Who’s Betting Against Canadian Cannabis Stocks

$ACB: Large Option Traders Are Selling The Aurora Cannabis Earnings Pop

$CRON $CGC $ACB: How Trade War 2.0 Benefits Struggling Cronos Stock

$CGC $ACB: 1 Common, but Sad, Fact About the Biggest Marijuana ETFs

$APHA $ACB: Canna Cabana Granted Membership into Canadian Franchise …

$ACB $TRTC $MJ $YOLO $HMLSF $ABBV: Aurora Cannabis Up 2.4%; Tera Tech Off 5.6%: Cannabis Stocks Mixed

$ACB: The 3 Best Marijuana Stocks to Buy Right Now

$ACB: Aurora Cannabis Exec Says Positive EBITDA Would Be ‘Game …

Latest News:

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences